A number of stocks were upgraded and downgraded by equities research analysts today, as reported by Analyst Ratings Network (http://bit.ly/arndailyr) and Equity Briefing:
Barclays Capital reiterated its overweight rating on shares of Halozyme Therapeutic HALO.
Janney Montgomery Scott reiterated its buy rating on shares of Hot Topic Inc HOTT.
Stifel Nicolaus upgraded shares of Idenix Pharmaceuticals, Inc. IDIX from a sell rating to a hold rating.
Oppenheimer raised its price target on shares of Jarden Co. JAH to $60.00. They have an outperform rating on the stock.
Imperial Capital lowered its price target on shares of US Airways Group, Inc. LCC from $22.00 to $19.00. They have an outperform rating on the stock.
Barclays Capital reiterated its overweight rating on shares of Liberty Capital LMCA.
Dougherty & Co reiterated its neutral rating on shares of MIPS Technologies, Inc. MIPS.
Janney Montgomery Scott reiterated its buy rating on shares of Children's Place Retail Stores, Inc. PLCE.
Nomura reiterated its reduce rating on shares of Prudential Public PUK.
Goldman Sachs reiterated its neutral rating on shares of Sina SINA.
Deutsche Bank reiterated its buy rating on shares of Sina SINA.
Barclays Capital reiterated its equal weight rating on shares of Solera Holdings, Inc. SLH.
Oppenheimer reiterated its outperform rating on shares of 3SBio Inc. SSRX.
KeyBanc initiated coverage on shares of Swift Transportation SWFT. They issued a hold rating on the stock.
MKM Partners reiterated its buy rating on shares of Targacept Inc. TRGT.
UBS AG reiterated its buy rating on shares of Wintrust Financial WTFC.
Deutsche Bank upgraded shares of Xueda Education XUE from a hold rating to a buy rating.
Stay on top of analysts' coverage with Analyst Ratings Network's free daily email newsletter that provides a concise list of analysts' upgrades, downgrades and initiations. Register at http://bit.ly/arndailyr
Content and Media Contact: newseditor@equitybriefing.com
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Equity Briefing via Thomson Reuters ONE
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.